help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on May 6, 2008
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2007-2138
This Article
Right arrow Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Google Scholar
Right arrow Articles by Feigerlová, E.
Right arrow Articles by Tauber, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Feigerlová, E.
Right arrow Articles by Tauber, M.
Related Collections
Right arrow Metabolism
Right arrow Obesity
Right arrow Pediatric Endocrinology

Submitted on September 21, 2007
Accepted on April 29, 2008

Hyperghrelinemia precedes obesity in Prader-Willi syndrome

Eva Feigerlová, Gwenaëlle Diene, Françoise Conte-Auriol, Catherine Molinas*, Isabelle Gennero, Jean-Pierre Salles, Catherine Arnaud, and Maïthé Tauber*

Centre de référence du syndrome de Prader-Willi, Department of Endocrinology, Bone Diseases, Genetics and Gynaecology. Children's Hospital, CHU-Toulouse, France; Laboratoire de Biochimie 3, Institut Fédératif de Biologie, Hôpital Purpan, TSA 40031, 31059 Toulouse Cedex 9, France; INSERM, U563, University Paul Sabatier, Toulouse, France; INSERM, U558, University Paul Sabatier, Toulouse, France

* To whom correspondence should be addressed. E-mail: molinas.c{at}chu-toulouse.fr or tauber.mt{at}chu-toulouse.fr.

Background: High plasma ghrelin levels have been reported in Prader-Willi syndrome (PWS). However, little is known about plasma ghrelin in these children during the first years of life characterized by a failure to thrive.

Objective: To investigate total plasma ghrelin levels in children with PWS and in controls from 2 months to 17 years.

Subjects and methods: Forty children with PWS (24 boys 16 girls, median age 3.6 years, median BMI Z-score 0.3) were compared to 84 controls (57 boys 27 girls median age 4.2 years median BMI Z-score 0.1) Children were then divided into 2 groups according to age and GH treatment.

Results: Median plasma ghrelin levels were significantly higher in children with PWS compared to controls at any age (568 vs. 173, p<0.0001) and decreased with age in both groups (p<0.0001). In the whole group of PWS, we found an inverse relationship between ghrelin and BMI Z-score, insulin, HOMA-IR, leptin and lean mass. Plasma ghrelin levels were higher in children with PWS than in controls, both in the youngest children below 3 years who were not receiving GH (771 vs. 233 p<0.0001) and in the children over 3 years all of whom were treated with GH (428 vs. 159 p<0.0001).

Conclusions: Plasma ghrelin levels in children with PWS are elevated at any age, including during the first years of life, thus preceding the development of obesity.


Key words: ghrelin • Prader-Willi syndrome • infants • children • BMI







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society